Home > Animal Health & Nutrition > Veterinary Medical Devices > Companion Diagnostics Market

Companion Diagnostics Market Share

Report ID: GMI3972
Published Date: Jul 2019
Report Format: PDF

Download Free Sample

Companion Diagnostics Market Share

Some of the notable players operating in the companion diagnostics market are :

Roche
Pfizer
Merck
Astra Zeneca
Bristol Myers Squibb
Amgen
Biogen
Eli Lilly
Myriad Genetics
Johnson & Johnson
Becton
Dickinson and Company
Abbott

Industry players are adopting strategies such as new product launches, collaborations and mergers and acquisitions to grab high revenue share.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of companion diagnostics exceeded USD 2 billion in 2018 and is poised to grow at over 19% CAGR between 2019 and 2025.

North America market size is estimated to expand at more than 18% CAGR during the forecast timeline impelled by increasing prevalence of chronic diseases and growing geriatric population susceptible to these diseases.

Asia Pacific market revenue is anticipated to witness around 20.5% growth through 2025. Government initiatives for providing effective treatment to cancer patients will propel the regional market expansion.

Some of the notable players operating in the market are Roche, Pfizer, Merck, Astra Zeneca, Bristol Myers Squibb, Amgen, Biogen, Eli Lilly, Myriad Genetics, Johnson & Johnson, Becton, Dickinson and Company, and Abbott.

Hospital end-use segment dominated around 40% market share in 2018 owing to increasing patient pool due to high prevalence of chronic disorders.